{
    "nctId": "NCT00202059",
    "briefTitle": "Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer",
    "officialTitle": "The Effects of Zoledronic Acid (Zometa) and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "PREVENTION",
    "enrollmentCount": 72,
    "primaryOutcomeMeasure": "Change in Bone Mineral Density from baseline to 12 months after beginning chemotherapy",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Women with Stage I - II breast cancer\n* Ages 40 - 55\n* Pre- or peri-menopausal\n* Within 1 month of beginning adjuvant or neoadjuvant chemotherapy\n* Baseline lumbar spine and total hip BMD \\> -2.0 SD\n* Able to read and write English\n* Signed consent form\n\nExclusion Criteria:\n\n* Previous treatment with bisphosphonates\n* Laboratory evidence of renal disease\n* Previous TRAM flap reconstructive surgery\n* Positive pregnancy test\n* Mental illness that precludes the patient from giving informed consent\n* Laboratory evidence of hepatic disease",
    "sex": "FEMALE",
    "minimumAge": "40 Years",
    "stdAges": "ADULT"
}